Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,251,771    

Indirect Value

   $375,195,594      
Total Shares   71,480,988      
Total Value   $537,447,365      


Halozyme Therapeutics Inc $162,231,150 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,231,150 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-16 4 B $5.73 $147,834 I/I 25,800 243,964 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-17 4 B $5.98 $251,160 I/I 42,000 285,964 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-18 4 B $5.76 $212,124 I/I 36,827 322,791 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-19 4 B $6.02 $360,598 I/I 59,900 382,691 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-20 4 B $5.85 $1,026,675 I/I 175,500 558,191 2.25 -
CLDA Clinical Data Inc Director   –       •       •   2008-06-20 4 B $16.49 $98,693 I/I 5,985 3,380,985 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-23 4 B $5.58 $4,154,573 I/I 713,232 1,271,423 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-23 4 B $5.51 $157,845 I/I 28,463 1,299,886 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-08-09 4 B $5.88 $4,341,386 I/I 738,331 738,331 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-08-10 4 B $6.13 $1,604,031 I/I 261,669 1,000,000 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-14 4 B $8.13 $1,788,600 I/I 220,000 1,220,000 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-15 4 B $8.18 $1,985,319 I/I 242,704 1,462,704 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-16 4 B $8.19 $1,437,509 I/I 175,520 1,638,224 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-21 4 B $8.04 $454,075 I/I 56,477 1,694,701 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-22 4 B $8.11 $447,234 I/I 55,146 1,749,847 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-23 4 B $8.00 $1,328,800 I/I 166,100 1,915,947 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-15 4 B $7.35 $3,142,720 I/I 427,581 3,333,528 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-16 4 B $7.44 $2,566,130 I/I 344,910 3,678,438 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-17 4 B $7.50 $2,242,553 I/I 299,007 3,977,445 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-01 4 B $7.39 $732,201 I/I 99,080 283,840 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-04 4 B $7.37 $660,691 I/I 89,646 328,663 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-05 4 B $7.48 $40,863 I/I 5,463 331,394 2.25 -
PRPO Precipio Inc 10% Owner   –       –       •   2013-01-25 4 B $0.00 $0 I/I 6,000,000 1,849,181 1.42 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-03-27 4 B $25.72 $6,249,986 I/I 243,001 243,001 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-05-09 4/A B $13.42 $233,239 I/I 17,248 129,794 2.64 -
  271  Records found
  1   2   3   4   5   6   7  8   9   10   11      
  Page 7 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us